ClinicalTrials.Veeva

Menu

Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Dermatologists

Pfizer logo

Pfizer

Status

Completed

Conditions

Psoriasis
Arthritis, Psoriatic
Skin Diseases, Papulosquamous

Treatments

Drug: etanercept

Study type

Observational

Funder types

Industry

Identifiers

NCT00293709
B1801126
0881A6-102036

Details and patient eligibility

About

The purpose of this study is to evaluate the safety profile and the effectiveness of etanercept under usual care settings in patients with PsA treated by dermatologists.

Full description

Non-interventional study: subjects to be selected according to the usual clinical practice of their physician

Enrollment

129 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Clinical diagnosis of Psoriatic Arthritis

Exclusion criteria

  • Sepsis or risk for sepsis,
  • Acute infection,
  • Hypersensitive against Etanercept

Trial design

129 participants in 1 patient group

Patients with Psoriatic Arthritis
Treatment:
Drug: etanercept

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems